Hematology meetings & conferences

National Hemophilia Foundation 65th Annual Meeting

October 3-5, 2013 Anaheim, California

Sickle Cell Disease Association of America 41st Annual Convention

September 24 – 27, 2013 Linthicum, Maryland

Since 1972, the Sickle Cell Disease Association of America, Inc. has served as America’s only voluntary national organization working full-time to resolve issues surrounding sickle cell disease. SCDAA is comprised of over 59 community based member organizations serving patients and their families in over 300 communities in North America. The 41st Annual Convention will be held on September 24 – 27, 2013 in Linthicum, MD.

3rd Global Congress for Consensus in Pediatrics & Child Health

February 13-16, 2014 Bangkok, Thailand

The concept for the CIP congress and program was developed for Pediatricians working in Primary and Secondary Care, as well as for specialists in the diverse areas of Pediatrics, Pediatric Surgeons, Family Medicine Doctors, General Practitioners, Researchers and Policy Makers

Main Topics

Primary Care

Neonatology

Pediatric Allergy & Immunology

Critical & Intensive Care

Pediatric Dermatology

Emergency Medicine

Pediatric Education

Pediatric Endocrinology

Pediatric Gastroenterology

Social Pediatrics

Pediatric Genetics

Hematology & Oncology

Infectious Diseases and Vaccinology

Pediatric Nephrology

Pediatric Neurology

Developmental-Behavioral Pediatrics

Pulmonology and Sleep Medicine

Pediatric Psychiatry

Pediatric Radiology

Pediatric Rheumatology

Pediatric Nutrition

Pediatric Sports Medicine

Adolescent Health

Surgery and its specialties

Rare and Orphan diseases

Pharmacology and Toxicology

Contact Us

Paragon Conventions
Tel: +41 (0)22 533 0948 Fax: +41 (0)22 580 2953
Email: cip@cipediatrics.org

Cancer in Africa: Bridging Science and Humanity

21-24 November 2013 Durban, South Africa

The African Organisation for Research and Training in Cancer is pleased to announce its 9th International Conference on Cancer in Africa. It will take place in Durban, South Africa from 21-24 November 2013 at the International Convention Centre Durban.

Held every two years, the AORTIC conferences provide a unique platform to bring together leading African and international health care professionals in cancer care, advocates, leaders in Government, and various members of the international health industry and global cancer community to meet and discuss cancer-related matters and proffer solutions to significantly reduce the impact of cancer in Africa and indeed around the world. To make a difference, AORTIC invites you, as a committed member of the international cancer control community, to contribute to and listen to world-renowned speakers, to network with colleagues and professionals from all over the world, and to be exposed to the latest research findings in the cancer arena.

The target audience for AORTIC’s 9th International Cancer Conference is anyone interested in the cancer burden in Africa, including physicians, nurses, social workers, researchers, and representatives of NGOs and international businesses.

The programme will address cutting edge cancer management and basic science and clinical research on cancers relevant to Africa. This will include the following topics: National Cancer Control Plans (NCCPs), Cancer Registration, Basic Sciences, Genetics, Epigenetics, Site-specific Cancers, Biomarkers, Radiation, Chemotherapy, Epidemiology, HIV-AIDS-related Cancers, Haematology, Cancer Advocacy, Tobacco-related Cancers, Paediatric Oncology, Palliative Care, and Oncology Nursing.

The Bone Marrow Niche, Stem Cells, and Leukemia: Impact of Drugs, Chemicals, and the Environment

May 29 - 31, 2013 The New York Academy of Sciences

Presented by Rutgers, The State University of New Jersey and the New York Academy of Sciences

Over 20,000 Americans are diagnosed each year with bone marrow failure syndromes. Environmental, chemical, and genetic factors have been linked to the development of lymphomas, leukemias, and myelodysplastic syndromes (MDS). Additionally, some anti-cancer drugs have been shown to themselves induce DNA damage and secondary cancers. In light of increasing societal exposure to toxic environmental agents that may be carcinogenic, including chemicals and pharmaceuticals, we face the potential for a rise in the incidence of bone marrow failure and malignancy. In order to better understand leukemia it may be necessary to examine it from the perspective that it is an environmental disease.

To date, two separate groups of scientists and physicians have been studying bone marrow: toxicologists who examine the effects of chemicals and the environment on healthy marrow, and hematologists and oncologists who investigate bone marrow abnormalities and malignancies. Thus, there is a clear, unmet need for collaboration between these fields within academia, industry, and government in order to accelerate our investigation and understanding both of basic bone marrow biology and chemically-induced diseases of the marrow.

This 2.5-day conference will bring together representatives from two areas of research, toxicology and hematology, around a jointly shared goal — to better understand, prevent, and treat myeloid neoplasms. Conference Sessions will combine basic science and toxicology research at the level of the bone marrow niche with clinical findings from healthy subjects and patients. Topics for discussion will include bone marrow niche structure and function, the maturation and differentiation of healthy and leukemogenic hematopoietic stem cells, and the environmental, chemical, and genetic factors involved in the development of myeloid abnormalities including MDS and acute myeloid leukemia (AML). The meeting will feature a series of plenary lectures, panel discussions, a poster session, and short talk presentations selected from abstracts submitted by early career investigators.

European Academy of Paediatrics 2013 Congress and MasterCourse

19-22 September, 2013 Lyon, France

The 2013 EAP Congress and MasterCourse, EAP will continue our  mission to train, educate, and update those professionals taking care of children, while at the same time stimulating and allowing the delegates the opportunity to meet and/or create personal professional network of colleagues and friends. The 2013 EAP Congress is the perfect setting to get the most updated, state-of-the-art information on the latest developments in research and clinical practice in the main areas of Paediatrics. It also provide the opportunity to debate on controversial issues and to contribute to the progress of the practice of paediatrics.

Congress Topics

    
Adolescent Medicine
Allergy and Immunology
Critical / Emergency Care
Endocrine & Diabetes
Gastroenterology and Nutrition
Genetic & Metabolic
Hemato - Oncology
Infectious Diseases

Neonatology
Nephrology
Neurology
Obesity
Paediatric Tropical Medicine
Primary Care
Respiratory
Rheumatology

MasterCourse Topics

Gastroenterology
Nutrition

Paragon-Conventions
18 Avenue Louis-Casai
1209 Geneva
Switzerland

Tel: +41 22 5330 948
Fax: +41 22 5802 953
Email: congress@eapaediatrics.eu
http://www.paragon-conventions.com

3rd World Congress of the International Society for Fertility Preservation (ISFP)

November 7-9, 2013 Valencia, Spain

We invite you to take part in the 3rd World Congress on the International Society for Fertility Preservation (ISFP) which will take place in Valencia, Spain on November 7-9, 2013.

Fertility preservation is a substantial quality of life issue for young cancer survivors. As a consequence, the demand for fertility preservation has dramatically increased. The aim of the Congress is to update current scientific and clinical development of fertility preservation strategies. The Congress will not only propagate the current knowledge but also provide an opportunity for networking.

This congress is designed for reproductive endocrinologists, hematology-oncologists, gynecologic oncologists, psychologists, basic scientists, clinical researchers, oncology nurses, REI nurses, oncology social workers and others interested in fertility preservation.

During this congress, participants will be able to:

- Educate medical professionals to facilitate FP referrals
- Define the ethical and legal issues related to FP
- Explain the impact of cancer treatment on fertility and reproduction.
- Evaluate the current status of gamete Cryopreservation.
- Assess the strategies and values of emerging technology in ovarian transplantation.
- Recognize basic physiology and effects of Cryopreservation.
- Analyze physiology and current techniques of folliculogenesis and IVM.
- Identify new fertility preservation technologies